|
|
|
|
|
|
|
|
|
05.05.25 - 14:39
|
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference (PR Newswire)
|
|
CEO Leonard Mazur to present on Thursday, June 5, 2025, at 3:10 pm ET CRANFORD, N.J., May 5, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) and its oncology subsidiary, Citius Oncology, Inc. (Nasdaq: CTOR), today announced that Leonard Mazur, Chairman and Chief Executive......
|
|
|
27.03.25 - 22:33
|
The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight (PR Newswire)
|
|
With the emergence of novel therapies and expanded indications, the United States IL-2 market is projected to reach USD 4 billion by 2034. Key players driving this expansion include Iovance Biotherapeutics, Eisai, Citius Pharmaceuticals, Nektar Therapeutics, Mural Oncology, Corvus......
|
|
|
26.11.24 - 08:03
|
XFRA : 47N0: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
CITIUS PHARMAC. DL -,001 47N0 US17322U3068 BAW/UFN...
|
|
25.11.24 - 23:57
|
XFRA : NEW INSTRUMENT AVAILABLE - 26.11.2024 - US17322U3068 (XETRA)
|
|
Das Instrument 47N0 US17322U3068 CITIUS PHARMAC. DL -,001 EQUITY hat seinen ersten Handelstag am 26.11.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N
The instrument 47N0 US17322U3068 CITIUS PHARMAC. DL -,001 EQUITY has its first trading date on 26.11.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
|
|
25.11.24 - 16:52
|
XFRA : ISIN Change (XETRA)
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
US15130G8087 Cemtrex Inc. 25.11.2024 US15130G8814 Cemtrex Inc. 26.11.2024 Tausch 35:1
SE0008212161 Svenska Aerogel Holding AB 25.11.2024 SE0023440557 Svenska Aerogel Holding AB 26.11.2024 Tausch 100:1
CA53044R2063 Liberty Defense Holding Ltd. 25.11.2024 CA53044R8839 Liberty Defense Holdings Ltd. 26.11.2024 Tausch 10:1
US17322U2078 Citius Pharmaceuticals Inc. 25.11.2024 US17322U3068 Citius Pharmaceuticals Inc. 26.11.2024 Tausch 25:1
LU2391723694 Perimeter Solutions S.A. 25.11.2024 US71385M1071 Perimeter Solutions Inc. 26.11.2024 Tausch 1:1...
|
|